CapsoVision Inc. (CV) has emerged as a stock to watch following a sharp rise in trading activity and a strong move in its share price. The stock closed at $11.80, up 32.73%, and continued climbing in after-hours trading to $18.04, marking a notable surge only months after its June 2025 IPO. The company is gaining attention as it expands its commercial footprint, advances new clinical programs, and strengthens its technology pipeline, supported by accelerating product adoption and several recent developments in the medical technology space.
CapsoVision is a commercial-stage medical technology company focused on developing and marketing endoscopic video imaging devices for internal visualization of the gastrointestinal (GI) system.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.